Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Chronic Venous Insufficiency: later-stage trial registry

1 of 4 indexed Chronic Venous Insufficiency trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Chronic Venous Insufficiency: 4 US clinical trials tracked, 1 recruiting.

Chronic Venous Insufficiency is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Tactile Medical, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-venous-insufficiency

OPEN 1 | RECR 25% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Venous Insuffici (th…25%
Open-enrollment share among volume-matched conditions near Chronic Venous Insufficiency

Chronic Venous Insufficiency lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Venous Insufficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Venous Insufficiency is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Chronic Venous Insufficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

EVLT 980nm diode laser system Device
1 trials
ClosureFAST radiofrequency catheter Device
1 trials
Ablation of the Incompetent Greater Saphenous Vein Procedure
1 trials
Dual Action Pneumatic Compression Device
1 trials
Venclose MAVEN System (digiRF generator w MAVEN catheter) Device
1 trials
Venclose System (digiRF generator w EVSRF catheter) Device
1 trials
Dayspring Device
1 trials

US sites by state

Facility locations filed on Chronic Venous Insufficiency trials. A trial with sites in several states counts in each.

Virginia 2 trials
New York 2 trials
New Jersey 2 trials
Texas 1 trials
North Carolina 1 trials
Michigan 1 trials
Massachusetts 1 trials
Hawaii 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Venous Insufficiency page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Chronic Venous Insufficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tactile Medical sponsors the most Chronic Venous Insufficiency trials on record, review their full trial history before evaluating a specific study. See Tactile Medical's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Venous Insufficiency condition card totals 4 registered trials; most-linked intervention EVLT 980nm diode laser system; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.